- Evolus to Report First Quarter Financial Results on May 7, 2024
- Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Evolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Evolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stock
- Evolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance
- Evolus Announces Results from European Head-to-Head Filler Trial
- Evolus to Participate in Upcoming Leerink Partners and Barclays Investor Conferences
- Evolus to Report Fourth Quarter and Year End 2023 Results and Provide Business Update on March 7, 2024
More ▼
Key statistics
On Friday, Evolus Inc (EOLS:NMQ) closed at 13.30, -13.82% below its 52-week high of 15.43, set on Mar 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.40 |
---|---|
High | 13.54 |
Low | 13.20 |
Bid | 11.65 |
Offer | 13.90 |
Previous close | 13.22 |
Average volume | 651.88k |
---|---|
Shares outstanding | 61.37m |
Free float | 49.40m |
P/E (TTM) | -- |
Market cap | 816.28m USD |
EPS (TTM) | -1.08 USD |
Data delayed at least 15 minutes, as of May 03 2024 21:00 BST.
More ▼